| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2020 | Jun 3, 2020 | Iterum Therapeutics plc | 10% Owner | Sell | 20.0 | -500,000 | -28.96% | ✗ | $812.1K |
| Nov 15, 2019 | Nov 19, 2019 | NextCure, Inc. | 10% Owner | Buy | 96.3 | +150,000 | 5.95% | ✗ | $5.5M |
| Nov 12, 2019 | Nov 12, 2019 | Galera Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +750,000 | 32.14% | ✗ | $9M |
| May 13, 2019 | May 15, 2019 | NextCure, Inc. | 10% Owner | Buy | 100.0 | +400,000 | 18.85% | ✗ | $6M |
| May 30, 2018 | May 30, 2018 | Iterum Therapeutics plc | 10% Owner | Buy | 100.0 | +500,000 | 40.77% | ✗ | $6.5M |
| May 12, 2015 | May 14, 2015 | aTYR PHARMA INC | 10% Owner | Buy | 100.0 | +320,000 | 20.70% | ✗ | $4.5M |